Boike, L., Henning, N. J. & Nomura, D. K. Advances in covalent drug discovery. Nat. Rev. Drug Discov. 21, 881–898 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Liu, R., Yue, Z., Tsai, C.-C. & Shen, J. Assessing lysine and cysteine reactivities for designing targeted covalent kinase inhibitors. J. Am. Chem. Soc. 141, 6553–6560 (2019).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Ferlenghi, F. et al. A sulfonyl fluoride derivative inhibits EGFRL858R/T790M/C797S by covalent modification of the catalytic lysine. Eur. J. Med. Chem. 225, 113786 (2021).

Article  CAS  PubMed  Google Scholar 

Hett, E. C. et al. Rational targeting of active-site tyrosine residues using sulfonyl fluoride probes. ACS Chem. Biol. 10, 1094–1098 (2015).

Article  CAS  PubMed  Google Scholar 

Chen, P. et al. 2-Ethynylbenzaldehyde-based, lysine-targeting irreversible covalent inhibitors for protein kinases and nonkinases. J. Am. Chem. Soc. 145, 3844–3849 (2023).

Article  CAS  Google Scholar 

Kawano, M. et al. Lysine-reactive N-acyl-N-aryl sulfonamide warheads: improved reaction properties and application in the covalent inhibition of an ibrutinib-resistant BTK mutant. J. Am. Chem. Soc. 145, 6202–26212 (2023).

Article  Google Scholar 

Gabizon, R. et al. A simple method for developing lysine targeted covalent protein reagents. Nat. Commun. 14, 7933 (2023).

Article  ADS  CAS  PubMed  PubMed Central  Google Scholar 

Yang, T. et al. Reversible lysine-targeted probes reveal residence time-based kinase selectivity. Nat. Chem. Biol. 18, 934–941 (2022).

Article  CAS  PubMed  PubMed Central  Google Scholar 

Woyach, J. A. et al. Resistance mechanisms for the Bruton’s tyrosine kinase inhibitor ibrutinib. N. Engl. J. Med. 370, 2286–2294 (2014).

Article  PubMed  PubMed Central  Google Scholar